Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Haploidentical Transplant Using Selective Ex-Vivo Tcrαβ Depleting and Memory T Cell Add-Back Results in More Favorable Gvhd-Free /Relapse Free Survival (GRFS) As Compared to Post-Transplant Cyclophosphamide for Adults with Hematological Malignancies - a Comparative Analysis of 170 Patients in a Multicenter Study in Singapore

Victor Ling Wei Teik, Yeh Ching Linn, Michelle Limei Poon, Jeffrey Quek, Lip Kun Tan, Zi Yi Lim, Colin Phipps Diong, Balamurugan Vellayappan, Joanne Lee, William YK Hwang, Hein Than, Aloysius YL Ho, Ian Wu, Yang Liang Boo, Teck Guan Soh, Gina Gan, Yvonne Su Ming Loh, Yin Jie Koh, Liang Piu Koh

Blood (2022) 140 (Supplement 1): 10500–10501.

https://doi.org/10.1182/blood-2022-168851

Published: 2022

Journal Articles

Haploidentical Hematopoietic Cell Transplantation of Ex Vivo Tcrαβ-Depleted Grafts with CD45RA-Depleted Memory T Cell Add-Back Reduces Chronic Graft-Versus-Host Disease and Results in Favourable Gvhd-Relapse Free Survival: 5-Year Follow-up of 107 Patients Treated in a Multicenter Study in Singapore

Blood (2022) 140 (Supplement 1): 4707–4708.

https://doi.org/10.1182/blood-2022-168995

Published: 2022

Journal Articles

HLA-Haploidentical Hematopoietic Cell Transplantation of Ex Vivo Tcrαβ-Depleted Grafts with CD45RA-Depleted Memory T Cell Add-Back in Adults and Children with Hematological Malignancies: 4-Year Follow-up of Multicenter Study in Singapore

Ian Q Wu, Yeh Ching Linn, Yang Liang Boo, Rajat Bhattacharyya, Zi Yi Lim, Michelle Poon, Michaela Su-Fern Seng, Poh Lin Tan, Colin Phipps, Balamurugan Vellayappan, Ah Moy Tan, Lip Kun Tan, Yvonne Su Ming Loh, Teck Guan Soh, Gina Gan, Yin Jie Koh, Wing H. Leung, Liang Piu Koh

Blood (2021) 138 (Supplement 1): 555.

https://doi.org/10.1182/blood-2021-152372

Published: 2021

Journal Articles

Phase I/II Dose-Escalation Study of Lenalidomide in Combination with R-GDP for Treatment of Transplant-Ineligible Relapsed/Refractory Diffuse Large B-Cell Lymphoma Followed By Maintenance Lenalidomide

Colin Phipps, MD, Chandramouli Nagarajan, MBBS, Lawrence Ng, MBBS, Jane L Chua, Yunxin Chen, MBBS, Shin Yeu Ong, MD, Melinda Si Yun Tan, MBBS, Nicholas Francis Grigoropoulos, MD PhD, Sathish Gopalakrishnan, MD, Heng Joo Ng, MBBS, William YK Hwang, MBBS, Yeow Tee Goh, MBBS, Yuh Shan Lee, MBBS

Blood (2020) 136 (Supplement 1): 25–26.

https://doi.org/10.1182/blood-2020-142275

Published: 2020

Journal Articles

HLA-Haploidentical Hematopoietic Cell Transplantation after TCR-Αβ and CD45RA+ Depletion Following Reduced Intensity Conditioning in Adults and Children with Hematological Malignancies: Three-Year Follow-up of Multicenter Study in Singapore

Yang Liang Boo, MD, Yeh Ching Linn, MBBS, MRCP, Rajat Bhattacharyya, Michelle Li Mei Poon, MBBS, MRCP, Zi Yi Lim, MB ChB, Michaela Su-Fern Seng, MBBS, Poh Lin Tan, MBBS, Colin Phipps Diong, MB BCh BAO, Balamurugan Vellayappan, MBBS, Ah Moy Tan, MD, Lip Kun Tan, MBBS, FRCP, FRCPath, Yvonne Su Ming Loh, MBBS, Teck Guan Soh, Gina Gan, Yin Jie Koh, Wing Hang Leung, MBBS, Liang Piu Koh, MBBS, MRCP

Blood (2020) 136 (Supplement 1): 8–9.

https://doi.org/10.1182/blood-2020-138638

Published: 2020

Journal Articles

Treatment Outcomes of Early-Stage Natural-Killer/T-Cell Lymphomas Treated with Chemoradiotherapy: Data from 3 Tertiary Cancer Centres in Singapore

Ya Hwee Tan, MBBS, MRCP, Siqin Zhou, MSc, Liu Xin, Soon Thye Lim, MBBS, MRCP, FAMS, Miriam Tao, MBBS, FAMS, FHKAM, FHKCP, MRCP, Daryl Tan, MBBS, MRCP, Michelle Poon, MBBS, MRCP, FRCPATH, Mohamad Farid, MBBS, MMed, MRCP, Colin Phipps Diong, Yuh Shan Lee, Shin-Yeu Ong, MD, Nicholas Francis Grigoropoulos, Kheng Wei Yeoh, MBBS, MSc, MRCP, MPH, FRCR (Clinical Oncology), Nagavalli Somasundaram, MBBS, MRCP, Eileen Yi Ling Poon, MBBS, MRCP, MMED, Jason Yongsheng Chan, MBBS, MRCP, Esther Wei Yin Chang, MD MRCP, Tiffany Tang, MBBS, MRCP

Blood (2019) 134 (Supplement_1): 5274.

https://doi.org/10.1182/blood-2019-125085

Published: 2019

Journal Articles

HLA-Haploidentical Hematopoietic Cell Transplantation after TCR-Αβ and CD45RA+ Depletion Following Reduced Intensity Conditioning in Adults and Children with Hematological Malignancies- Two-Year Follow-up of Multicenter Study in Singapore

Li Mei Poon, MBBS, MRCP, FRCPath, Yeh Ching Linn, MBBS, MRCP, Poh Lin Tan, Ziyi LIM, Balamurugan Vellayappan, Rajat Bhattacharyya, Ah Moy Tan, MD, Lip Kun Tan, MBBS, FRCP, FRCPath, Teck Guan Soh, Colin Phipps Diong, Wing H. Leung, MD PhD, Liang Piu Koh, MBBS, MRCP

Blood (2019) 134 (Supplement_1): 2039.

https://doi.org/10.1182/blood-2019-128014

Published: 2019

Journal Articles

Prognostic Value of the Novel Mucosal Associated Lymphoid Tissue Prognostic Index (MALT-IPI) in Marginal Zone Lymphoma (MZL) Cases

Blood (2018) 132 (Supplement 1): 2885.

https://doi.org/10.1182/blood-2018-99-118364

Published: 2018

Journal Articles

Outcome of Primary Mediastinal B Cell Lymphoma: Comparative Analysis of 123 Patients Treated with Different Strategies

Blood (2017) 130 (Supplement 1): 1564.

https://doi.org/10.1182/blood.V130.Suppl_1.1564.1564

Published: 2017

Journal Articles

PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase

Yok-Lam Kwong, Thomas S. Y. Chan, Daryl Tan, Seok Jin Kim, Li-Mei Poon, Benjamin Mow, Pek-Lan Khong, Florence Loong, Rex Au-Yeung, Jabed Iqbal, Colin Phipps, Eric Tse

Blood (2017) 129 (17): 2437–2442.

https://doi.org/10.1182/blood-2016-12-756841

Published: 2017

Includes: Supplemental data

Journal Articles

Time from Diagnosis to Initiation of Curative Chemotherapy Affects Outcomes in DLBCL - Data from a Large Asian Cohort

Colin Phipps, MBBS, MRCP, FRCPath, Yuh Shan Lee, MBBS, MRCP, FRCPath, Chandramouli Nagarajan, MBBS, MD MRCP, Yunxin Chen, MBBS, MRCP, FRCPath, Allan ZK Goh, Lay Poh Khoo, BSc, Kevin Tay, MD, Miriam Tao, MD, Richard Quek, Tiffany Tang, MD, Mohamad Farid, MD, Soon Thye Lim, MBBS, MRCP, Sathish Kumar Gopalakrishnan, FRCPath, Nicholas F Grigoropoulos, MRCP, FRCPath, Yvonne Loh, MBBS, MRCP, Daryl Tan, MBBS, MRCP, William YK Hwang, MBBS, MRCP, FRCP, Yeow Tee Goh, MD

Blood (2016) 128 (22): 1871.

https://doi.org/10.1182/blood.V128.22.1871.1871

Published: 2016

Journal Articles

Role of Consolidation High Dose Chemotherapy (HDC) with Autologous Stem Cell Transplant (ASCT) Support in Patients with Peripheral T-Cell Lymphoma Who Achieved Complete Remission (CR1) Following First Line Induction Chemotherapy

Lay Poh Khoo, BSc, Tiffany Tang, MD, Suk Teng Chin, BSc, Jeslin Ha, BSc, Colin Phipps, MBBS, MRCP, FRCPath, Yuh Shan Lee, MBBS, MRCP, FRCPath, Mohamad Farid, MD, Kevin Tay, MD, Miriam Tao, MD, Richard Hong Hui Quek, MD, Soon Thye Lim, MD

Blood (2016) 128 (22): 4640.

https://doi.org/10.1182/blood.V128.22.4640.4640

Published: 2016

Journal Articles

Impact of Post-Remission Consolidation Modalities in the Clinical Outcomes of Acute Myeloid Leukemia Patients in First Remission - Is There a Role for Autologous Hematopoietic Stem Cell Transplant?

May Anne Cheong, MBBS, MRCP, Gee Chuan Wong, MBBS, MRCP, FRCP, William YK Hwang, MBBS, MRCP, FRCP, Ho YL Aloysius, MBBS, MRCP, FRCPath, Yeh Ching Linn, MBBS, MRCP, Yeow-Tee YT Goh, MD, Yvonne Loh, MBBS, MRCP, Sathish Kumar, MBBS, MRCP, FRCPath, Colin Phipps, MBBS, MRCP, FRCPath, Zhentang Lao, MBBS, MRCP

Blood (2015) 126 (23): 3184.

https://doi.org/10.1182/blood.V126.23.3184.3184

Published: 2015

Journal Articles

A Phase 2 Study of Panobinostat (PAN) in Combination with Bortezomib (BTZ) in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL) or NK/T-Cell Lymphoma (NKL)

Yeow-Tee Goh, MBBS,MMed, William YK Hwang, FRCP, FAMS, MMed, MRCP, MBBS, Colin Phipps Diong, Yap chun Hsien, bsc, Kevin Tay, MD, Soon Thye Lim, MBBS, MRCP, Yuh Shan Lee, MBBS, MRCP, Soo Chin Ng, MD, S Fadilah, MBBS, Won Seog Kim, Daryl Tan, MD

Blood (2014) 124 (21): 503.

https://doi.org/10.1182/blood.V124.21.503.503

Published: 2014

Journal Articles

Use of Valacyclovir for the Treatment of Cytomegalovirus Antigenemia after Hematopoietic Stem Cell Transplantation

Shin-Yeu Ong, MD MRCP, MSE, Ha Thi Thu Truong, BSc, Aloysius Y Ho, Yeh Ching Linn, MRCP, Yeow-Tee YT Goh, MD, Colin Phipps Diong, Yvonne Loh, MBBS, MRCP, William YK Hwang, FRCP, FAMS, MMed, MRCP, MBBS

Blood (2014) 124 (21): 1098.

https://doi.org/10.1182/blood.V124.21.1098.1098

Published: 2014

Journal Articles

Impact Of Pre-Transplant Rituximab Sensitivity In Relapsed Follicular Lymphoma On Outcome After Autologous Transplant

Colin Phipps, MD, Ajay K. Gopal, MD, Barry E. Storer, PhD, Ryan D. Cassaday, MD, Oliver W. Press, MD, PhD, Brian G. Till, MD, John M. Pagel, MD, PhD, Mary Phillip, Maria Corinna Palanca-Wessels, M.D., Ph.D., William I. Bensinger, MD, Leona Holmberg, MD, PhD, Andrei R. Shustov, MD, Damian J. Green, MD, Thomas Chauncey, MD, PhD, David G. Maloney, MD, PhD, Edward N. Libby, III, MD

Blood (2013) 122 (21): 3365.

https://doi.org/10.1182/blood.V122.21.3365.3365

Published: 2013

Journal Articles

Cost and Utilization Of Stored Autologous PBSC To Support Tandem ASCT In MM Patients In The Era Of Novel Agent Therapy

Colin Phipps, MD, Michael L. Linenberger, MD, Damian J. Green, MD, M. Corinna Palanca-Wessels, MD, PhD, Pamela S. Becker, MD, PhD, Laura S. Connelly-Smith, MBBCh, DM, Nicholas Burwick, MD, Zandra K. Klippel, MD, William I. Bensinger, MD, Leona Holmberg, MD, PhD, Edward N. Libby, III, MD

Blood (2013) 122 (21): 4507.

https://doi.org/10.1182/blood.V122.21.4507.4507

Published: 2013

Journal Articles

Bortezomib (BTZ) and Panobinostat (PAN) Combination Is Effective in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL) or NK/T-Cell Lymphoma (NKL) and Maintenance Treatment May Be Essential for Sustained Response

Daryl Tan, MD, William YK Hwang, MBBS, FRCP, FAMS, Colin Phipps Diong, Wee Lee Goh, BSC, Lionel K.Y See, BSc, Yiong Huak Chan, PHD, Soon Thye Lim, MRCP MBBS, Soo Chin Ng, MBBS MRCP, S Fadilah, MBBS, Soo-Yong Tan, MBBS, FRCPath, DPhil, Won Seog Kim, MD, Yeow Tee Goh, MD

Blood (2012) 120 (21): 3669.

https://doi.org/10.1182/blood.V120.21.3669.3669

Published: 2012

Journal Articles

Incorporation of Bortezomib Into Frontline Treatment of Multiple Myeloma According to Risk Stratification Shifts the Most Significant Prognostic Indicator From Cytogenetics to the Quality of Induction Response

Daryl Tan, MBBS, MRCP, Bernard K.C Yap, BSc, Lionel K.Y See, BSc, Grace Kam, MBBS, MRCP, Colin Phipps Diong, Yuh Shan Lee, MBBS, MRCP, Dawn Mya, MBBS, MRCP, William Hwang, MBBS, FRCP, FAMS, Yeow Tee Goh, MD

Blood (2010) 116 (21): 3056.

https://doi.org/10.1182/blood.V116.21.3056.3056

Published: 2010

NARROW

HLA-Haploidentical Hematopoietic Cell Transplantation of Ex Vivo Tcrαβ-Depleted Grafts with CD45RA-Depleted Memory T Cell Add-Back in Adults and Children with Hematological Malignancies: 4-Year Follow-up of Multicenter Study in Singapore

Phase I/II Dose-Escalation Study of Lenalidomide in Combination with R-GDP for Treatment of Transplant-Ineligible Relapsed/Refractory Diffuse Large B-Cell Lymphoma Followed By Maintenance Lenalidomide

HLA-Haploidentical Hematopoietic Cell Transplantation after TCR-Αβ and CD45RA+ Depletion Following Reduced Intensity Conditioning in Adults and Children with Hematological Malignancies: Three-Year Follow-up of Multicenter Study in Singapore

Treatment Outcomes of Early-Stage Natural-Killer/T-Cell Lymphomas Treated with Chemoradiotherapy: Data from 3 Tertiary Cancer Centres in Singapore

HLA-Haploidentical Hematopoietic Cell Transplantation after TCR-Αβ and CD45RA+ Depletion Following Reduced Intensity Conditioning in Adults and Children with Hematological Malignancies- Two-Year Follow-up of Multicenter Study in Singapore

Prognostic Value of the Novel Mucosal Associated Lymphoid Tissue Prognostic Index (MALT-IPI) in Marginal Zone Lymphoma (MZL) Cases

Outcome of Primary Mediastinal B Cell Lymphoma: Comparative Analysis of 123 Patients Treated with Different Strategies

PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase

Time from Diagnosis to Initiation of Curative Chemotherapy Affects Outcomes in DLBCL - Data from a Large Asian Cohort

Role of Consolidation High Dose Chemotherapy (HDC) with Autologous Stem Cell Transplant (ASCT) Support in Patients with Peripheral T-Cell Lymphoma Who Achieved Complete Remission (CR1) Following First Line Induction Chemotherapy

Impact of Post-Remission Consolidation Modalities in the Clinical Outcomes of Acute Myeloid Leukemia Patients in First Remission - Is There a Role for Autologous Hematopoietic Stem Cell Transplant?

A Phase 2 Study of Panobinostat (PAN) in Combination with Bortezomib (BTZ) in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL) or NK/T-Cell Lymphoma (NKL)

Use of Valacyclovir for the Treatment of Cytomegalovirus Antigenemia after Hematopoietic Stem Cell Transplantation

Impact Of Pre-Transplant Rituximab Sensitivity In Relapsed Follicular Lymphoma On Outcome After Autologous Transplant

Cost and Utilization Of Stored Autologous PBSC To Support Tandem ASCT In MM Patients In The Era Of Novel Agent Therapy

Bortezomib (BTZ) and Panobinostat (PAN) Combination Is Effective in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL) or NK/T-Cell Lymphoma (NKL) and Maintenance Treatment May Be Essential for Sustained Response

Incorporation of Bortezomib Into Frontline Treatment of Multiple Myeloma According to Risk Stratification Shifts the Most Significant Prognostic Indicator From Cytogenetics to the Quality of Induction Response

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only